| Literature DB >> 20548899 |
Ah Young Cho1, Yeon Sook Kim, Yoon Hoh Kook, Shin Ok Kim, Seung Ju Back, Young Joon Seo, Jeung Hoon Lee, Young Lee.
Abstract
Mycobacterium massiliense, an emerging pathogen that is increasingly reported as a causative agent in infections occurring during medical procedures, is difficult to be identified using conventional methods. Here we report the case of a cutaneous M. massiliense infection that was associated with repeated surgical procedures and that was identified via a comparative sequence analysis of rpoB and hsp65. The patient showed a substantial response to treatment with a combination of antimicrobial therapies consisting of clarithromycin, amikacin, and cefoxitin for 6 months.Entities:
Keywords: Mycobacterium massiliense
Year: 2010 PMID: 20548899 PMCID: PMC2883389 DOI: 10.5021/ad.2010.22.1.114
Source DB: PubMed Journal: Ann Dermatol ISSN: 1013-9087 Impact factor: 1.444